Sumitomo Life Insurance CO Regeneron Pharmaceuticals, Inc. Transaction History

Sumitomo Life Insurance CO

$5.08 Billion
Q3 2024

A detailed history of Sumitomo Life Insurance CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Life Insurance CO holds 3,174 shares of REGN stock, worth $2.23 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

3,174

Previous 1,747 81.68%

Holding current value

$2.23 Million

Previous $1.84 Million 81.7%

% of portfolio

0.07%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$1024.09 - $1201.76 $1.46 Million - $1.71 Million	1,427 Added 81.68%	3,174 $3.34 Million
Q2 2024 Jul 19, 2024	SELL	$883.2 - $1071.19 $198,720 - $241,017	-225 Reduced 11.41%	1,747 $1.84 Million
Q1 2024 Apr 26, 2024	SELL	$902.69 - $993.35 $71,312 - $78,474	-79 Reduced 3.85%	1,972 $1.9 Million
Q4 2023 Jan 30, 2024	BUY	$775.18 - $881.7 $485,262 - $551,944	626 Added 43.93%	2,051 $1.8 Million
Q3 2023 Oct 23, 2023	SELL	$692.45 - $844.37 $570,578 - $695,760	-824 Reduced 36.64%	1,425 $1.17 Million
Q2 2023 Jul 20, 2023	SELL	$700.03 - $830.35 $135,105 - $160,257	-193 Reduced 7.9%	2,249 $1.62 Million
Q1 2023 Apr 27, 2023	SELL	$680.49 - $826.97 $12,248 - $14,885	-18 Reduced 0.73%	2,442 $2.01 Million
Q4 2022 Jan 17, 2023	SELL	$705.89 - $766.39 $25,412 - $27,590	-36 Reduced 1.44%	2,460 $1.78 Million
Q3 2022 Oct 31, 2022	SELL	$573.97 - $724.32 $164,155 - $207,155	-286 Reduced 10.28%	2,496 $1.72 Million
Q2 2022 Jul 22, 2022	BUY	$548.35 - $738.84 $11,515 - $15,515	21 Added 0.76%	2,782 $1.65 Million
Q1 2022 Apr 27, 2022	SELL	$595.12 - $698.43 $23,804 - $27,937	-40 Reduced 1.43%	2,761 $1.93 Million
Q4 2021 Feb 04, 2022	SELL	$543.48 - $670.97 $58,695 - $72,464	-108 Reduced 3.71%	2,801 $1.77 Million
Q3 2021 Oct 25, 2021	SELL	$574.03 - $680.96 $70,031 - $83,077	-122 Reduced 4.03%	2,909 $1.76 Million
Q2 2021 Jul 20, 2021	SELL	$472.8 - $558.54 $230,726 - $272,567	-488 Reduced 13.87%	3,031 $1.69 Million
Q1 2021 Apr 27, 2021	SELL	$446.73 - $548.2 $76,390 - $93,742	-171 Reduced 4.63%	3,519 $1.67 Million
Q4 2020 Feb 05, 2021	SELL	$478.3 - $607.98 $171,709 - $218,264	-359 Reduced 8.87%	3,690 $1.78 Million
Q3 2020 Oct 29, 2020	SELL	$544.75 - $658.21 $115,487 - $139,540	-212 Reduced 4.98%	4,049 $2.27 Million
Q2 2020 Jul 22, 2020	SELL	$493.32 - $643.92 $195,354 - $254,992	-396 Reduced 8.5%	4,261 $2.66 Million
Q1 2020 May 01, 2020	BUY	$336.18 - $494.43 $21,179 - $31,149	63 Added 1.37%	4,657 $2.27 Million
Q4 2019 Jan 24, 2020	BUY	$274.13 - $376.51 $70,177 - $96,386	256 Added 5.9%	4,594 $1.73 Million
Q3 2019 Oct 24, 2019	SELL	$273.46 - $318.39 $139,191 - $162,060	-509 Reduced 10.5%	4,338 $1.2 Million
Q2 2019 Jul 26, 2019	BUY	$299.6 - $414.82 $51,531 - $71,349	172 Added 3.68%	4,847 $1.52 Million
Q1 2019 Apr 17, 2019	SELL	$372.08 - $439.57 $187,900 - $221,982	-505 Reduced 9.75%	4,675 $1.92 Million
Q4 2018 Jan 24, 2019	BUY	$335.82 - $403.04 $42,313 - $50,783	126 Added 2.49%	5,180 $1.94 Million
Q3 2018 Oct 18, 2018	SELL	$351.14 - $408.51 $35,114 - $40,851	-100 Reduced 1.94%	5,054 $2.04 Million
Q2 2018 Jul 23, 2018	BUY	$284.6 - $344.99 $62,896 - $76,242	221 Added 4.48%	5,154 $1.78 Million
Q1 2018 Apr 27, 2018	SELL	$315.82 - $393.78 $68,532 - $85,450	-217 Reduced 4.21%	4,933 $1.7 Million
Q4 2017 Feb 01, 2018	SELL	$358.63 - $469.95 $90,374 - $118,427	-252 Reduced 4.66%	5,150 $1.94 Million
Q3 2017 Oct 17, 2017	BUY	$431.38 - $504.0 $2.33 Million - $2.72 Million	5,402	5,402 $2.42 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Life Insurance CO with notifications on news.

Account

Sumitomo Life Insurance CO Regeneron Pharmaceuticals, Inc. Transaction History